Home
Topics
Affordable Care Act
COVID-19
Global Health Policy
Health Costs
Health Misinformation and Trust
HIV/AIDS
Medicaid
Medicare
Mental Health
Patient and Consumer Protections
Private Insurance
Racial Equity and Health Policy
Uninsured
Women’s Health Policy
Polling
State Health Facts
State Health Facts
Custom State Reports
KFF Health News
Social Impact Media
Peterson-KFF Health System Tracker
Newsroom
Newsroom
News Releases
Events
Subscribe to Emails
Cite Us/Reprint
Media Contacts
Join Our Team
About Us
About KFF
From Drew Altman
Our People
Our Programs
KFF Board
Contact Us
Support Our Work
Conference Centers
San Francisco, CA
Washington, DC
The independent source for health policy research, polling, and news.
menu
The independent source for health policy research, polling, and news.
Donate
Follow us
Email
Open Search...
Search KFF.org
Gun Violence
ACA Open Enrollment
Abortion in the U.S.
Charts & Slides
Slides
Slideshows
Home
Charts & Slides
Medicare's Share of Prescription Drug Spending Increased More Than 10 Percentage Points…
Medicare’s Share of Prescription Drug Spending Increased More Than 10 Percentage Points Since 2006
Published:
Feb 01, 2019
Share this page on Facebook (opens in a new tab)
Share this page on X (opens in a new tab)
Share this page on LinkedIn (opens in a new tab)
Share this page via Email
Print this page
Download Image
Source
KFF analysis of CMS National Health Expenditure Data for Historical (CY2005-2017) and Projected (CY2018-2026) Retail Prescription Drug Expenditures.
Topics
Medicare
Tags
Prescription Drugs
Medicare Part D
Chart of the Week
Explore Charts & Slides by Topic
Explore KFF Slides by Topic
Affordable Care Act
Coronavirus (COVID-19)
Global Health Policy
Health Costs
Health Misinformation and Trust
HIV/AIDS
Medicaid
Medicare
Mental Health
Other
Private Insurance
Racial Equity and Health Policy
Uninsured
Women's Health Policy
Search Charts & Slides For:
All charts & slides
Also of Interest
10 Essential Facts About Medicare and Prescription Drug Spending
The Out-of-Pocket Cost Burden for Specialty Drugs in Medicare Part D in 2019